Loading...
InVivo Therapeutics Holdings Corporation
NVIV•NASDAQ
HealthcareBiotechnology
$0.32
$-0.17(-34.28%)
InVivo Therapeutics Holdings Corporation (NVIV) Quarterly Earnings Reports & Financial Results
Analyze InVivo Therapeutics Holdings Corporation’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of InVivo Therapeutics Holdings Corporation’s actual vs. estimated earnings across recent quarters.
No data available
InVivo Therapeutics Holdings Corporation (NVIV) Quarterly Earnings Details
Detailed breakdown of InVivo Therapeutics Holdings Corporation’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.